Skip to main content
BioFish Holding AS logo

BioFish Holding AS — Investor Relations & Filings

Ticker · BFISH ISIN · NO0010955198 LEI · 549300BU24YQIH7G3038 OL Agriculture, forestry and fishing
Open in API
Filings indexed 318 across all filing types
Latest filing 2023-09-22 Board/Management Inform…
Country NO Norway
Listing OL BFISH

About BioFish Holding AS

https://biofish.no/

BioFish Holding AS is a land-based producer of high-quality smolt and post-smolt for the aquaculture industry. The company operates a production facility that utilizes Recirculating Aquaculture System (RAS) technology to cultivate robust and healthy fish, which can be grown to approximately 500 grams. The facility's strategic location in a high-density farming area allows for shorter transportation, which is beneficial for fish health and logistics. The company's focus is on maintaining strong biological performance and scaling production.

Recent filings

Filing Released Lang Actions
BioFish Holding AS: Change of CEO
Board/Management Information Classification · 100% confidence The document explicitly announces a change in the Chief Executive Officer (CEO) of BioFish Holding AS, naming the incoming and outgoing individuals and stating the effective date. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management.
2023-09-22 English
BioFish Holding AS: Change of CEO
Board/Management Information Classification · 100% confidence The document explicitly announces a change in the Chief Executive Officer (CEO) of BioFish Holding AS, naming the new CEO and detailing the departure of the previous CEO. This directly corresponds to the definition of 'Board/Management Information' (Code: MANG), which covers announcements of changes in senior management.
2023-09-22 English
BioFish : 2Q 2023 - Presentation
Interim / Quarterly Report Classification · 100% confidence The document is titled '2Q 2023 Report' and contains comprehensive financial statements, including Profit & Loss, Assets, Equity, Liabilities, and Cash Flow, along with detailed accounting notes and management commentary. It covers a period shorter than a full fiscal year (the second quarter of 2023). It is not an announcement of a report, but the report itself, containing substantive financial data. Q2 2023
2023-09-21 English
BioFish : 2Q 2023 - Presentation
Report Publication Announcement Classification · 98% confidence The document text is very short (672 characters) and explicitly states: 'Please find enclosed the financial report for BioFish for 2Q 2023.' The title also indicates it is a '2Q 2023 - Presentation'. This structure—a brief announcement stating that a report (in this case, a presentation covering the 2Q results) is enclosed or attached—fits the definition of a Report Publication Announcement (RPA) rather than the full report itself (which would likely be classified as IR if comprehensive). Since it is a presentation accompanying the results, and the text is an announcement of that material, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule.
2023-09-21 English
BioFish – Successful delivery of post-smolt batch
Regulatory Filings Classification · 99% confidence The document is a short announcement (1211 characters) detailing the successful completion of a specific delivery ('Successful delivery of post-smolt batch') and providing an update on expected Q3 2023 revenues relative to FY 2022. It references a previous stock exchange announcement. This is not a full financial report (like 10-K or IR), nor is it a formal dividend notice, management change, or capital action. It is a specific operational and financial update that doesn't fit the primary definitions for ER (Earnings Release, which usually covers the whole quarter's results) or MDA (Management Discussion & Analysis). Given its nature as a specific operational update released via a stock exchange mechanism, and its brevity, it best fits the general 'Regulatory Filings' (RNS) category, which serves as a catch-all for important, non-standard announcements, or potentially an Earnings Release (ER) if it's considered the initial highlight release, but RNS is safer for specific operational news not tied to a standard quarterly filing cycle.
2023-09-01 English
BioFish – Successful delivery of post-smolt batch
Regulatory Filings Classification · 90% confidence The document is a very short announcement (1374 characters) detailing the successful completion of a specific operational milestone: the delivery of a large batch of post-smolt fish, referencing a previous contract announcement. It provides operational updates, confirms the delivery schedule, and gives an outlook on Q3 2023 revenues relative to 2022. This is not a full financial report (10-K, IR), an earnings release (ER) which usually contains full period results, or a management discussion (MDA). It is a specific operational update that doesn't fit the defined categories well, but it is a general announcement made to the market. Given its brevity and nature as a specific operational update that doesn't fit the core financial/governance categories, it most closely aligns with a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were providing preliminary results, but it focuses more on operational achievement than financial figures. Since it is a specific, non-standard operational update, RNS is the most appropriate fallback.
2023-09-01 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.